LA JOLLA, CA—Richard Stryjewski, a financial leader with deep expertise in the non-profit research sector, has been appointed as Chief Financial Officer at La Jolla Institute for Immunology. In his role, he will lead financial planning and operations to advance essential growth and ensure the Institute’s long-term financial security.
“I am excited to welcome a talented, experienced expert to direct financial planning in support of our research and operational goals,” said LJI President and CEO Erica Ollmann Saphire, Ph.D. “Richard is passionate about supporting scientific research and uniquely equipped to thrive in the environment of an independent, world-class research institute.”
An active California Certified Public Accountant, Stryjewski started his career at Ernst & Young LLP, and subsequently held various accounting and finance positions with multiple large organizations including PacifiCare Health Systems and the Walt Disney Company. Most recently, he spent 12 years at Scripps Research, where he oversaw general accounting, financial reporting, budget, treasury, risk management, compliance, endowment accounting, and donor financial stewardship.
“Finance touches every aspect of a research organization and my greatest satisfaction comes from knowing I can play a role in advancing the goals of the Institute,” said Stryjewski. “LJI is one of the shining stars on the mesa, and I look forward to working with the Institute’s leaders to support the pioneering science that’s happening here every day.”
Stryjewski is a Southern California native, and holds a Bachelor’s Degree in Accounting from the University of Southern California.
About La Jolla Institute for Immunology
The La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading toward its goal: life without disease.